MedPath

Effects of Fructose and Exercise on Hepatic Lipid Metabolism

Not Applicable
Completed
Conditions
Metabolism
Interventions
Behavioral: weight maintenance, low sugar diet
Behavioral: weight maintenance, high fructose diet
Behavioral: weight maintenance, high fructose diet+ exercise
Registration Number
NCT01121003
Lead Sponsor
University of Lausanne
Brief Summary

8 healthy male volunteers will be studied each on 3 occasions, ie

* after 4 days on a weight maintenance diet containing 5% simple sugars + low physical activity

* after 4 days on a weight maintenance diet containing 30% fructose + low physical activity

* after 4 days on a weight maintenance diet containing 30% fructose + high physical activity At the end of each of these 3 periods, fructose induced hepatic de novo lipogenesis (13C palmitate synthesis in response to ingestion of a 13C fructose load) and plasma VLDL-triglyceride kinetics (measured with a bolus of 2H-labeled glycerol) will be measured

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
8
Inclusion Criteria
  • age between 18 and 30 years
  • males
  • BMI between 19 and 25
  • low to moderate physical activity (< 3 sessions/week)
Exclusion Criteria
  • smoking
  • consumption of alcohol>50g/week
  • consumption of drugs or illicit substances
  • food allergies

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Low fructose diet/no exerciseweight maintenance, low sugar diet-
high fructose diet/no exerciseweight maintenance, high fructose diet-
high fructose diet+exerciseweight maintenance, high fructose diet+ exercise-
Primary Outcome Measures
NameTimeMethod
Hepatic de novo lipogenesisafter 4 days on controlled diet+exercise

Measurement of 13C VLDL palmitate after ingestion of 13C fructose

Secondary Outcome Measures
NameTimeMethod
Plasma VLDL-triglyceride kineticsafter 4 days on controlled diet+exercise

Modelling of 2H5-glycerol incorporation in VLDL afetr administration of a bolus of 2H5 glycerol

Trial Locations

Locations (1)

Centre Hospitalier Universitaire Vaudois

🇨🇭

Lausanne, VD, Switzerland

© Copyright 2025. All Rights Reserved by MedPath